Machine learning model predicts eGFR slope in chronic kidney disease, suggesting improved outcomes in primary care.
Chronic kidney disease (CKD) is a significant global health challenge, yet the application of eGFR slope as a metric for CKD progression remains underdeveloped in primary care settings. Using data from J-CKD-DB-Ex, Japan’s largest CKD database, we developed and validated a machine learning-based model to predict eGFR slope. The study included 10,474 patients aged ≥ 18 years with eGFR < 60 mL/min/1.73 m² or proteinuria at baseline. The median age of participants was 69.0 years [IQR: 62.0–77.0], and 52% (5,493/10,474) of the cohort were male. The Median baseline eGFR was 52.7 mL/min/1.73 m² [IQR: 44.7–57.8]. Predictors included demographic, clinical, and laboratory data. We compared three models: linear regression, LightGBM, and LSTM networks. Among 10,474 patients (median age 69.0 years), the LightGBM model achieved superior performance (RMSE = 2.95 mL/min/1.73 m²/year) compared to LSTM (RMSE = 3.94) and conventional linear regression (RMSE = 15.87). The model was implemented as a web-based application for clinical use. This machine learning-based prediction model achieves superior accuracy in estimating eGFR trajectory and enables real-time prediction using single time-point data. The web-based tool supports early identification of high-risk patients, enabling timely interventions and specialist referrals in primary care settings.
No takes yet. Share an insight, caveat, or question.
Nagasu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: